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Introduction (9) 
 Aging is  natural process 
 
 Senescent cells replaced with juvenile 
 
 Senescence appear in different level of tissue ,organ, cell and 
molecule 
 
Senescence , derived from senex  
meaning ”old man” 
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 Introduction(9) 
 
 
 There is various agent like  DNA damage,  
 
        oxidative demolition ,Telomerase activity and  
 
        metabolical flow can accelerate aging process 
 
 
 Anti-aging medicine goal depend on health 
span by interference in this pathways 
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 History (9) 
 
     Three hypothesis about aging event  
 
I. accumulation hypothesis (by Medawar)in1952 
 
II. Antagonistic pleotropic hypothesis 
 
I. Somatic transmitters(by Kirkwood)in1996 
 
Anti- aging medicine got current after 2000 
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Main effective factors in cell senescence (9) 
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DNA damage (3) 
.. 
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 Genetic context (5) 
 
 
  Aging and longevity are controlled by genome 
 
  Aging can be suppressed and life span increased 
 
 
  organisms with low half life like nematode caenorabditis elegans are  
used in gerantogens study 
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Genetic context , metabolic follow & signal transduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          Insulin/insulin-like growth factor pathway with influence on lifespan 
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      Researches discovered with mutation in genes daf-2 or age-1 lifespan                    
increase 
 
     The orthologs gene mammalian respectively 
InR and PI3K  
 
       DAF-16  human orthologs is FOXO 
 
     Age-1 
                                                                  DAF-16                              Increase lifespan 
    Daf-2 
                                                                longevity 
                                                                    gene 
 
 
     Age-1 or daf-2 and their orthologs are suitable  
        target for RNAi         
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How free radicals cause aging 
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http://www.mdpi.com/1420-3049/21/2/163 
 Any one of them have some pharmaceutical target 
     
 
 Biotechnology role in aging(9) 
 
 
    Detection, decrease of aging process 
       and increase of health longevity 
 
 
   Creation of aging process and death in 
         malignant, cancerous and infection cells     
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(9) 
15 
oxidants 
Inhibitors and Inducers of 
Apoptosis proteins 
Gerantogen activity 
Telomerase activity 
Mitochondrial protein and  
Membrane potential 
Aging and biotechnology relationship 
 
 
   For accomplish the above cases biotechnology Needs some techniques 
       such as: 
 
 
•   RNAi (siRNA & miRNA) 
 
•   Drug delivery techniques materials Nano 
 
•   Cell therapy, Gene therapy 
 
•   Tissue engineering 
 
•   Recombinant antibody 
 
•   DNA vaccines 
 
 
             
              (9) 
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  RNAi-based therapeutic (6) 
 
 
    
 
    The induction of RNAi relies on small silencing RNA 
          affect specific messenger RNA(mRNA)degradation 
 
      siRNA and miRNA  have central function in RNAi technology 
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RNAi-based therapeutic 
SiRNA target genes disease 
HIV-Tat, HIV-Rev, HIV-Vif 
 
HPV-E6 & E7, HBV-S1,-S2,-S-X 
 
CCR5, CXCR4 ,CD4 
 
Viral 
P53 mutant, k-Ras, BCR- ABL, MDR1 
 
C-Raf, Bcl2, VEGF, PKC-a, B-catenin 
 
Cancer 
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two RNAi delivery strategies to target cancerous and viral 
Tissues;(6) 
 
I. Systemic administration 
II. Local administration 
 
 
 Local administration may be promising to overcome 
  systemic delivery disadvantage such as 
Liver toxicity and stimulation of immune response 
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RNAi-based therapeutic(6)   
 
 
 
 
 
 Oncology can benefit the most from this novel therapeutic strategy 
 
  Lung cancer is the most common cause of cancer-related death 
worldwide 
 
 
 
 
    
 
20 Aging and biotechnology relationship 
21 Aging and biotechnology relationship 
22 Aging and biotechnology relationship 
  modified siRNA platform (6) 
 
 
      E.g.: PnKRNA(proline naked RNA) and nkRNA(naked RNA) 
 
  With local delivery through inhalation 
 
  More resistant to degradation  because of their unique helical structure 
 
  Without inflammatory response in Intrapulmonary delivery 
 
  Lung and ayes, few organs successful 
       RNAi could be delivery of naked siRNA    
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Novel platform SiRNA (8) 
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 P-GP-mediated drug resistance (7) 
 
   P-glicoprotein pomp(p-gp)  a member of ABC –transporter family 
 
   Cause drug resistance in some age-related disease 
 
   Such as rheumatoid arthritis(RA) and alzymer 
 
    p-gp an excellent target to control these disease  
 
 
   TNF-a as a biological target for RA treatment 
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Relevance of p-Gp in drug resistance(RA) (7) 
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 Apoptosis-targeted therapies (2) 
 
 
      Apoptosis, programed cell death (PCD) maintains healthy ,survival/ 
           death balance in metazoan cell 
 
       Defect PCD cause cancer or autoimmunity  
          enhanced PCD cause degenerative disease, immunodeficiency, infertility 
 
    Inhibitor of apoptotic proteins (IAP) and FLICE-inhibitor protein (cFLIP), 
      central control point of PCD pathways, modulate by carcinogenesis signals 
 
 
        cFLICE ; cellular FADD –like interleukin-1beta converting enzyme 
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http://www.hindawi.com/journals/bmri/2014/616149/fig1/ 
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 Apoptosis-targeted therapies (2) 
 
 
       successful nonsurgical cancer cell eradication  approached 
       by induction of apoptosis 
 
        apoptotic-based therapy  is focused onBCL-2 family proteins 
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Shutting off gene 
transcription 
Inducing mRNA 
degradation by antisense 
oligonucleotides 
Directly attacking the 
proteins with small 
molecular drugs 
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Some anti apoptotic drug in cancer therapy (2) 
31 
Targeted 
molecule 
Modulatory 
function 
drug cancer 
Steroid/Rtinoide 
transcription  
factor(RAR,VDR 
Inhibit BCL-2 doxorubicin Breast cancer 
Interaction with 
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agonist) 
Prostate cancer 
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Inhibit BCL-2, 
BCL-xL 
HDAC 
inhibitors 
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BCL-2, BCL-
xL 
Inhibit BCL-2, 
MCL 
Synthetic BH3 
peptide 
Follicular 
lymphoma 
Bak and BaX Activate Bak 
and BaX 
Synthetic BH3 
peptide 
- 
CD20 Complement 
activation 
Monoclonal 
antibody 
Certain 
leukemia 
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 Telomerase-based therapies(4) 
 
     Telomeres are guanine-rich repeated sequences 
          located at the end of chromosomes 
 
      A number of protein are located on telomeres witch 
           protect telomeres by forming D-and T-loops 
 
      They function as a biological clock limiting the cell proliferation 
          with every next cell division  that accompanied by cell senescence, 
          mitotic crisis and apoptosis 
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 Telomerase –based therapies (4) 
 
      most cancer cells(~85%) reveal telomere length maintaince  that 
             is responsible for telomeres renewal during cell proliferation 
 
          cancer cells utilize telomerase for this purpose 
 
           the enzyme is a multisubunit rebonucleoprotein contains 
               catalytic subunit and RNA molecule as a template for 
                telomerase revers transcription(TERT)  
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Telomerase-based  therapies (4) 
 
     There is several strategies for  control telomerase in cancer cells 
 
       Antisense technology against telomerase RNA component(TR) 
          and telomerase revers transcriptase 
 
        Ribozyme against TERT 
 
     Modulation of interaction  with other proteins involved in the regulation      
of telomerase and telomeres 
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Transcriptional mechanism of telomerase regulation (4) 
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 Telomerase-based  therapies (4) 
 
     Natural-derived compounds with antitumor activity in the context 
      of telomerase regulation in breast cancer   
 
       butein(3,4,2’,4’-tetrahydroxy chalcone) 
           it cause dowregulation by suppression of TERT gene expression 
           in a C-myc depending manner 
 
        pectenotxin-2 dependent attenuation of TERT  expression was  
             mediated through suppression of C-myc and sp1-binding on the 
             regulatory region of TERT 
 
         C-myc  have role in TERT gene expression induction 
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 Telomerase-based  therapies (4) 
 
 
 
     silencing TERT and HER-2 (human epithelial grow factor-2) 
      by SiRNA technology increased radiosensivity  and down  
      regulation TERT/telomerase 
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Recent natural anti-aging compounds (1) 
41 
 
 
Compound name source application 
Grape-seed extract 
 
Fruit polyphenols& 
flavonoids 
Skin treatment 
Jojoba protein Jojoba plant Moisturizer& anti-
wrinkle 
Ferulic acid Plant phenolic 
compounds 
Anti-oxidant & anti-
inflammatory 
Berries - Cancer & improve 
brain function 
Extra virgin olive oil olive Reduce aging, cancer 
& cardiovascular 
diseases 
lycopene tomato Reduce cancer & 
aging risk 
Spirulia plankton Immune-stimulator & 
moisturizer 
Dark chocolates Cocoa bean Reduce skin 
inflammatory 
Kojic acid dipalmitate Japanese mushroom Invigorating & skin 
lightening 
Nano biotechnology effect in increasing longevity 
 
 
 
 
 
                                                                                                                                 
       - advance in joint                      -artificial organs           -development of            -local drug 
     displacement                          -in vivo sensors             cell-material                  delivery 
    -noninvasive &                        -local drug                     interaction                     -gene therapy  
     invasive diagnosis                   delivery                       -tissue scaffold                expansion 
    to fast disease follow              - nerves                        engineering                   -foppish  structures 
    up                                             stimulation                 -Genetical                      -fast diagnostic 
    - co-diagnostic                        -heart materials &        treatment of cell             approaches             
     devices                                     cordial disease            senescence 
    -cancer wise treatment              treatment                    - treatment  by 
                                                                                                    stem cells   
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Conclusion 
 Although aging is gradual and spontaneous changes in structure and  
function of living creature with time passing 
 
 
 
 Some disease such as  cardiovascular , cancer and accidents 
     are the main cause of death and early aging 
 
 
 
    
  Up to now the disease treatment were based on chemotherapy   
    drugs, different rays and surgery 
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conclusion 
Nowadays with use of medical biotechnology and related field to be 
able to Take a little step in order to have a health senescence cycle by; 
 
 Early diagnosis of disease, follow up treatment and recovery 
 
 Efficient delivery of drug to target point, make organ and different 
     biochemical sensors 
 
 Genetical drugs based on RNA and DNA  with attention to patient 
     genetical features 
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Thank for your time 
